Adverse Drug Reactions, Contraindications and Drug interactions of OTC Analgesics - PowerPoint PPT Presentation

About This Presentation
Title:

Adverse Drug Reactions, Contraindications and Drug interactions of OTC Analgesics

Description:

Mechanisms of all the reactions of OTC Analgesics are dealt in easy way. – PowerPoint PPT presentation

Number of Views:2705

less

Transcript and Presenter's Notes

Title: Adverse Drug Reactions, Contraindications and Drug interactions of OTC Analgesics


1
Adverse Drug Reactions, Contraindications and
Drug Interactions of OTC Analgesics
  • P.Naina Mohamed
  • Pharmacologist

2
Adverse Drug Reactions, Contraindications and
Drug Interactions
  • The basic knowledge of mechanisms underlying
    Adverse drug reactions, Contraindications and
    Drug interactions of OTC medicines provides the
    understanding of preventive measures.
  • Adverse drug reaction (ADR)
  • A response to a drug that is harmful or
    unpleasant and unintended and occurs at doses
    normally used in man for the prophylaxis,
    diagnosis or therapy of disease, or for
    modification of physiological function.
  • Contraindication
  • A condition which makes a particular treatment
    (medicine) or procedure potentially inadvisable.
  • Drug Interaction
  • A modification of the effect of a drug when
    administered with another drug, food, or herb.

3
OTC Analgesics
  • Non opioid or Non steroidal anti inflammatory
    drugs (NSAIDs) are available as OTC analgesics.
  • They block the synthesis of inflammatory
    prostaglandins by inhibiting Cycloxygenase (COX)
    enzyme and relieve pain, fever and inflammation.

4
OTC Analgesics
  • Commonly used OTC Analgesics
  • Non Opioid Analgesics
  • 1. Paracetamol
  • 2. Aspirin
  • Non Steroidal Anti inflammatory Drugs
    (NSAIDs)
  • 1. Ibuprofen
  • 2. Diclofenac
  • 3. Meloxicam
  • 4. Indomethacin
  • 5. Mefenemic Acid
  • 6. Ketoprofen
  • 7. Celecoxib

5
Non Opioid Analgesics
  • Paracetamol has only weak anti inflammatory
    property and it is indicated only for Pyrexia and
    Mild to moderate pain.
  • Aspirin has very less anti inflammatory activity
    compared to other NSAIDs and it is indicated only
    for the inhibition of Platelet aggregation, mild
    to moderate pain and pyrexia.

6
Paracetamol (Acetaminophen)
  • ADRs
  • Paracetamol produces rare adverse drug
    reactions such as
  • 1. Mild gastric discomfort (Nausea,
    Vomiting, Anorexia, Abdominal pain)
  • 2. Hypersensitivity reactions (Rash,
    urticaria, Angioedema, Anaphylaxis, etc.)
  • 3. Nephrotoxicity in toxic doses

7
Paracetamol (Acetaminophen)
  • Hepatotoxicity
  • Paracetamol causes liver damage
    (Hepatotoxicity) in toxic doses.
  • Paracetamol (Acetaminophen) overdose
  • Saturation of sulfate and glucuronide conjugation
    metabolic pathways
  • More paracetamol undergoes CYP2E1 metabolism
  • Excessive production of N-Acetyl P- benzo quinone
    imine (NAPQI)
  • Depletion of Glutathione (Natural antioxidant)
  • Liver damage (Hepatotoxicity)

8
Paracetamol (Acetaminophen)
  • Paracetamol induced hepatotoxicity can be treated
    by administering N-Acetyl Cysteine which is a
    precursor of Glutathione.
  • N-Acetyl Cysteine
  • Precursor of Glutathione
  • Increase the level of glutathione
  • Glutathione detoxifies NAPQI to form cysteine and
    other metabolites
  • Prevention of liver necrosis

9
Paracetamol (Acetaminophen)
  • Contraindications
  • 1. Hypersensitivity to Paracetamol
  • 2. Hepatic Impairment (Due to its Hepatoxic
    effects)
  • Drug Interactions
  • Paracetamol
  • Hyoscine butyl bromide (Buscopan)
  • M3 receptor blockade by Buscopan
  • Reduced gut motility
  • Increased gastric emptying time
  • Reduced absorption of Paracetamol

10
Paracetamol (Acetaminophen)
  • Drug Interactions
  • Paracetamol
  • Metoclopramide
  • D2 receptor blockade by Metoclopramide
  • Increased gut motility
  • Reduced gastric emptying time
  • Increased absorption of Paracetamol

11
Paracetamol (Acetaminophen)
  • Paracetamol
  • Alcohol
  • Alcohol induce the secretion of pro-inflammatory
    cytokines (TNF-alpha, IL6 and IL8), oxidative
    stress, lipid peroxidation, and acetaldehyde
    toxicity
  • Inflammation, apoptosis and fibrosis of liver
    cells
  • Increased risk of Hepatotoxicity

12
Paracetamol (Acetaminophen)
  • Paracetamol
  • Amyl nitrite, Sodium nitrite or Sodium
    thiosulphate
  • Nitrates induce the oxidation of Fe2 (Haeme) to
    form Fe3 (Met-Haeme)
  • Increased risk of methemoglobinemia
  • Fe3 ions cannot bind with oxygen
  • Reduced oxygen carrying capacity
  • Discolouration of skin, mouth or nail bed

13
Paracetamol (Acetaminophen)
  • Paracetamol Leflunomide, Teriflunomide or
    Lomitapide
  • Excessive levels of Liver enzymes like ALT AST
  • Increased risk of Hepatotoxicity

14
Paracetamol (Acetaminophen)
  • Paracetamol Prilocaine
  • Prilocaine metabolises to form O-Toluidine
  • O-Toluidine induce the oxidation of Fe2 to form
    Fe3
  • Increased risk of Methemoglobinemia
  • Reduced oxygen carrying capacity
  • Discolouration of Skin, Mouth or Nail bed

15
ASPIRIN
  • ADRs
  • 1. Risk of bleeding
  • 2. Aspirin induced Asthma
  • 3. GI bleeding
  • 4. Primary Respiratory Alkalosis

16
ASPIRIN
  • Risk of Bleeding
  • Aspirin blocks COX 1 more than COX 2 and has
    the increased risk of bleeding compared to other
    NSAIDs.
  • Aspirin
  • Blockade of COX 1 of platelets
  • Reduced Thromboxane A2 (TXA 2) synthesis
  • Decreased Platelet aggregation
  • Increased risk of Bleeding

17
ASPIRIN
  • Aspirin Induced Asthma (AIA)
  • Aspirin
  • Block Cyclooxygenase 1 (COX 1) enzyme
  • Inhibit synthesis of PGE2 in lungs
  • Relieving of Inhibitory effects of PGE2 on
    production of
  • Cysteinyl-Leukotrienes
  • Elevated levels of Cysteinyl-Leukotrienes
  • Acute bronchoconstriction , Rhinosinusitis
  • Bronchospasm and/or Laryngospasm, Rhinorrhea, and
  • Nasal congestion

18
ASPIRIN
  • GI bleeding
  • Aspirin
  • Block Cyclooxygenase 1 (COX 1) enzyme
  • Inhibition of PGE2 synthesis
  • Reduced mucous secretion and bicarbonate
    secretion
  • Damage of Gastro intestinal mucosa
  • Gastro intestinal ulceration
  • GI Hemorrhage, perforation
  • Life-threatening bleeding (Acute) and Anemia
    (Chronic)

19
ASPIRIN
  • Primary Respiratory Alkalosis
  • Aspirin (Anti infammatory dose)
  • Uncoupling oxidative phosphorylation
  • Increased CO2 production
  • Increased respiratory rate
  • Reduction of PCO2
  • Primary Respiratory alkalosis

20
ASPIRIN
  • Contraindications
  • 1. First and Third trimester of Pregnancy
  • 2. Bronchial asthma
  • 3. Patients with severe hepatic damage,
    hypoprothrombinemia, vitamin K deficiency, or
    hemophilia
  • 4. Active GI ulcer

21
ASPIRIN
  • Risk of gastroschisis
  • Aspirin
  • (First trimester of pregnancy)
  • Increased risk of gastroschisis

22
ASPIRIN
  • Risk of Maternal and Fetal bleeding
  • Aspirin
  • (Third trimester of Pregnancy)
  • Reduced TXA 2 synthesis
  • Inhibition of Platelet aggregation
  • Increased risk of maternal and fetal bleeding

23
ASPIRIN
  • Early closure of Ductus Arteriosus (DA)
  • Aspirin
  • (Third trimester of pregnancy)
  • Blockade of COX 1 enzyme
  • Reduced PG synthesis
  • Early closure of DA

24
ASPIRIN
  • Drug Interactions
  • ASPIRIN
  • Acetazolamide, Dorzolamide or Methazolamide
  • Aspirin competitively inhibits plasma protein
    binding of zolamides
  • Elevated concentrations of unbound (Free)
    zolamides
  • Ringing in your ears, headache, nausea, vomiting,
    dizziness, confusion, hallucinations, rapid
    breathing, fever, seizure (convulsions), or coma
  • Other Drug interactions
  • Similar to NSAIDs

25
NSAIDs
  • ADRs
  • 1. Gastro intestinal ulceration (Anorexia,
    nausea, dyspepsia, abdominal pain, and diarrhea)
  • 2. Hypersensitivity reactions (Pseudoallergic
    and allergic reactions)
  • 3. Risk of Hemorrhage
  • 4. Risk of Thrombosis
  • 5. Early closure of Ductus Arteriosus
  • 6. Renal Ischemia
  • 7. Risk of Edema

26
NSAIDs
  • Gastro intestinal Ulceration (Mechanism1)
  • NSAIDs (Oral)
  • Local irritation to gastric mucosa
  • Back diffusion of acid into gastric mucosa
  • Tissue damage
  • Gastro intestinal ulceration
  • Anorexia, nausea, dyspepsia, abdominal pain, and
    diarrhea

27
NSAIDs
  • Gastro intestinal Ulceration (Mechanism 2)
  • NSAIDs (Non selective)
  • Block Cyclooxygenase 1 (COX 1) enzyme
  • Inhibition of PGE2 synthesis
  • Reduced mucous secretion and bicarbonate
    secretion
  • Damage of Gastro intestinal mucosa
  • Gastro intestinal ulceration
  • GI Hemorrhage, perforation
  • Life-threatening bleeding (Acute) and Anemia
    (Chronic)

28
NSAIDs
  • Gastro intestinal Ulceration (Mechanism3)
  • NSAIDs
  • Block Cyclooxygenase 1 (COX 1) enzyme
  • Inhibit the synthesis of Potent vasodilators like
    PGE2 and PGI2 from vascular endothelium
  • Reduced gastric mucosal blood flow
  • Gastro intestinal ulceration

29
NSAIDs
  • Hypersensitivity reactions (Pseudoallergic
    reactions)
  • NSAIDs
  • Block Cyclooxygenase 1 (COX 1) enzyme
  • Inhibit synthesis of PGE2 in lungs
  • Relieving of Inhibitory effects of PGE2 on
    production of
  • Cysteinyl-Leukotrienes
  • Elevated levels of Cysteinyl-Leukotrienes
  • Bronchoconstriction , Rhinosinusitis
  • Bronchospasm and/or Laryngospasm, Rhinorrhea, and
  • Nasal congestion

30
NSAIDs
  • Hypersensitivity reactions (Pseudoallergic
    reactions)
  • NSAIDs
  • Block Cyclooxygenase 1 (COX 1) enzyme
  • Inhibit synthesis of Constitutive PGs
  • Acute urticaria and/or angioedema (skin, lips,
    and mouth)

31
NSAIDs
  • Hypersensitivity reactions (Allergic reactions)
  • NSAIDs
  • IgE mediated reaction
  • Allergic reactions (Urticaria, Angioedema or
    Anaphylaxis)

32
NSAIDs
  • Risk of Hemorrhage
  • NSAIDs
  • Blockade of COX 1 of platelets
  • Reduced Thromboxane A2 (TXA 2) synthesis
  • Decreased Platelet aggregation
  • Increased risk of Bleeding

33
NSAIDs
  • Risk of Thrombosis
  • NSAIDs
  • Blockade of COX 2 enzyme of blood vessels
  • Inhibition of Prostacyclin (PGI 2) synthesis
  • Reduced restriction on prothrombotic and
    atherogenic stimuli by PGI 2
  • Increased risk of thrombosis
  • Elevated risk of Myocardial infarction, Stroke

34
NSAIDs
  • Early Closure of Ductus Arteriosus
  • NSAIDs
  • (During last trimester of pregnancy)
  • Blockade of COX enzyme
  • Inhibition of Synthesis of Prostaglandins
  • Early closure of Ductus arteriosus (DA)
  • Fetal blood flows in to lungs
  • Respiratory failure, impaired right ventricular
    function, tricuspid regurgitation and right heart
    dilatation

35
NSAIDs
  • Renal Ischemia
  • NSAIDs
  • (In patients with CHF, CKD, etc)
  • Blockade of COX 2 enzyme of renal cells
  • Inhibition of synthesis of Vasodilator
    Prostaglandins (PGE 2 and PGI 2)
  • Reduction of renal blood vessel dilation and
    blood flow
  • Renal ischemia

36
NSAIDs
  • Risk of Edema
  • NSAIDs
  • (In patients with CHF, CKD, etc)
  • Blockade of COX 2 enzyme of renal cells
  • Inhibition of synthesis of Prostaglandins
  • Reduction of inhibitory effect of PGs on Cl
    reabsorption and ADH activity
  • Fluid retention
  • Edema and Hypertensive complications

37
NSAIDs
  • Contraindications
  • NSAIDs are contraindicated in the following
    conditions due to their adverse effects on the
    systems
  • Active gastric or duodenal ulcer
  • Bronchial Asthma
  • Third trimester of pregnancy

38
NSAIDs
  • Drug Interactions
  • NSAIDs
  • Warfarin, Apixaban, Rivaroxaban, Enoxaparin,
    Dalteparin, Aredeparin, Tinazaparin, Ibritumomab,
    Tositumomab, Cabozantinib, Ponatinib,
    Regoratinib, Prasugrel, Anisindione, Fondaparinux
    or Desirudin
  • Increased risk of Bleeding
  • (Due to the inhibition of platelet aggregation by
    NSAIDs)
  • Unusual bleeding or bruising, swelling, vomiting,
    blood in your urine or stools, headache,
    dizziness, or weakness

39
NSAIDs
  • Drug Interactions

NSAIDs Leflunomide, Teriflunomide or
Lomitapide Excessive levels of Liver enzymes
like ALT AST Increased risk of (Liver Damage)
Hepatotoxicity Fever, chills, joint pain or
swelling, unusual bleeding or bruising, skin
rash, itching, loss of appetite, fatigue, nausea,
vomiting, dark colored urine, light colored
stools, and/or yellowing of the skin or eyes
40
NSAIDs
  • Drug Interactions
  • NSAIDs
  • Adefovir, Cidofovir, Tenofovir, Tacrolimus,
    Sirolimus, Sodium Biphosphate or IV
    Immunoglobulins
  • Increased risk of kidney damage
  • Increased or decreased urination, sudden weight
    gain or weight loss, fluid retention, swelling,
    shortness of breath, muscle cramps, tiredness,
    weakness, dizziness, confusion, and irregular
    heart rhythm.

41
NSAIDs
  • Drug Interactions
  • NSAIDs
  • ACE inhibitors
  • Increased risk of Hyperkalemia
  • Bradycardia
  • Syncope in Elderly and cardiac patients

42
NSAIDs
  • Drug Interactions
  • NSAIDs
  • Corticosteroids or SSRIs
  • Increased GI complications

43
NSAIDs
  • Non Steroidal Anti inflammatory Drugs (NSAIDs)
  • 1. Ibuprofen
  • 2. Diclofenac
  • 3. Meloxicam
  • 4. Indomethacin
  • 5. Mefenemic Acid
  • 6. Ketoprofen
  • 7. Celecoxib
  • All the NSAIDs have more or
    less same adverse drug reactions (ADRs),
    Contraindications and Drug interactions.

44
REFERENCES
  • Goodman Gilman's The Pharmacological Basis of
    Therapeutics, 12e Laurence L. Brunton, Bruce A.
    Chabner, Björn C. Knollmann
  • Basic Clinical Pharmacology, 12e Bertram G.
    Katzung, Susan B. Masters, Anthony J. Trevor
  • Harrison's Online Featuring the complete
    contents of Harrison's Principles ofInternal
    Medicine, 18e
  • Principles and Practice of Hospital Medicine
    Sylvia C. McKean, John J. Ross, Daniel D.
    Dressler, Daniel J. Brotman, Jeffrey S. Ginsberg
  • BNF March 2013

45
REFERENCES
  • Tintinalli's Emergency MedicineA Comprehensive
    Study Guide, 7e Judith E. Tintinalli, J. Stephan
    Stapczynski, David M. Cline, O. John Ma, Rita K.
    Cydulka, and Garth D. MecklerThe American
    College of Emergency Physicians
  • Poisoning Drug Overdose, 6e Kent R. Olson
  • CURRENT Diagnosis Treatment Gastroenterology,
    Hepatology, Endoscopy, 2e Norton J.
    Greenberger, Richard S. Blumberg, Robert Burakoff
  • CURRENT Medical Diagnosis Treatment 2013
    Maxine A. Papadakis, Stephen J. McPhee, Eds.
    Michael W. Rabow, Associate Ed.
  • CURRENT Rheumatology Diagnosis Treatment,
    2eJohn B. Imboden, David B. Hellmann, John H.
    Stone

46
REFERENCES
  • http//xa.yimg.com/kq/groups/22038980/2115709304/n
    ame/Acetaminophen20Hepatotoxicity20and20Acute2
    0Liver20Failure.pdf
  • http//farncombe.mcmaster.ca/documents/WallaceBest
    PractResClinGastroenterol2000141147-159.pdf
  • http//onlinelibrary.wiley.com/doi/10.1111/j.1398-
    9995.1997.tb01039.x/pdf
  • http//idosi.org/gjp/4(1)10/4.pdf
  • http//www.uptodate.com/contents/nsaids-including-
    aspirin-allergic-and-pseudoallergic-reactions
  • http//www.drugs.com/drug_interactions.html

47
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com